Trivalent HBV Vaccine Superior in Efficacy in Adults 45 Years and Older
A Phase III study has found a trivalent hepatitis B virus (HBV) vaccine demonstrated superiority in adults 45 years and older and noninferior in adults older than 18 years compared with a monovalent vaccine.
Flu Vaccine May Reduce Risk of Heart Attack and Stroke in Hypertensive Individuals
A new study shows cardiovascular outcomes may improve in individuals with hypertension if they receive the influenza (flu) vaccine during the flu season.
Skin Patch Shows Promise for Delivery of Influenza Vaccine
Researchers at the University of Rochester Medical Center in New York City have developed a new type of skin patch that could replace needles as a method to deliver the influenza (flu) vaccine.
NIAID Awards $30 Million to Develop Tuberculosis Vaccine
The awards establish and provide up to seven years of support for three Immune Mechanisms of Protection Against Mycobacterium Tuberculosis (IMPAc-TB) Centers to elucidate the immune responses needed to protect against Mtb infection.
NIH to Evaluate Experimental Adjuvants for Seasonal Influenza Vaccine
The National Institutes of Health (NIH) is conducting an early-stage clinical trial to evaluate the safety and efficacy of two licensed seasonal influenza vaccines administered with or without novel adjuvants.
HPV Vaccine Exceeds Expectations by Providing Herd Immunity
A new study shows the HPV vaccine is far more effective than expected, with benefits extending beyond those who receive the vaccine.
Researchers Develop Vaccine Candidates to Prevent Epstein-Barr Virus
An NIH research team has determined how several antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory.
Stopping Alzheimer’s with a Preventative Vaccine?
Despite the many vaccine candidates undergoing clinical trials, experts doubt an effective vaccine for Alzheimer’s disease is on the horizon.
Sanofi Receives Narrow FDA Approval for Dengue Vaccine
FDA has given Sanofi SA’s dengue vaccine Dengvaxia a narrow approval since the vaccine can cause severe infections in some people.
Campaign Launched to Remind Families Teens Need Second Meningitis Booster Shot
The National Meningitis Association has launched a campaign to encourage more teens to get the meningitis booster.